# C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

> **NCT00688454** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 3392 (actual)

## Conditions studied

- Hypercholesteremia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00688454
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** —
- **Final completion:** 2008-01
- **Target enrollment:** 3392 (ACTUAL)
- **Last updated:** 2009-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688454, "C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00688454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*